Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Nutraceuticals for the treatment of hypercholesterolemia.

Mannarino MR, Ministrini S, Pirro M.

Eur J Intern Med. 2014 Sep;25(7):592-9. doi: 10.1016/j.ejim.2014.06.008. Epub 2014 Jul 2. Review.

PMID:
24997485
2.

Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study.

Cicero AF, Derosa G, Pisciotta L, Barbagallo C; SISA-PUFACOL Study Group.

J Med Food. 2015 Nov;18(11):1270-3. doi: 10.1089/jmf.2015.0024. Epub 2015 Aug 14.

3.

Joint position statement on "Nutraceuticals for the treatment of hypercholesterolemia" of the Italian Society of Diabetology (SID) and of the Italian Society for the Study of Arteriosclerosis (SISA).

Pirro M, Vetrani C, Bianchi C, Mannarino MR, Bernini F, Rivellese AA.

Nutr Metab Cardiovasc Dis. 2017 Jan;27(1):2-17. doi: 10.1016/j.numecd.2016.11.122. Epub 2016 Nov 22. Review.

PMID:
27956024
4.

Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients.

Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, Sposato B, Massaro R, Grieco F, Rosano G.

Adv Ther. 2011 Dec;28(12):1105-13. doi: 10.1007/s12325-011-0082-5. Epub 2011 Nov 21.

PMID:
22113535
5.

Effects of a nutraceutical combination (berberine, red yeast rice and policosanols) on lipid levels and endothelial function randomized, double-blind, placebo-controlled study.

Affuso F, Ruvolo A, Micillo F, Saccà L, Fazio S.

Nutr Metab Cardiovasc Dis. 2010 Nov;20(9):656-61. doi: 10.1016/j.numecd.2009.05.017. Epub 2009 Aug 20.

PMID:
19699071
6.
7.

Preventing cardiovascular heart disease: Promising nutraceutical and non-nutraceutical treatments for cholesterol management.

Johnston TP, Korolenko TA, Pirro M, Sahebkar A.

Pharmacol Res. 2017 Jun;120:219-225. doi: 10.1016/j.phrs.2017.04.008. Epub 2017 Apr 10. Review.

PMID:
28408313
8.

Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk.

Bianconi V, Mannarino MR, Sahebkar A, Cosentino T, Pirro M.

Curr Cardiol Rep. 2018 May 25;20(7):53. doi: 10.1007/s11886-018-0994-7. Review.

PMID:
29802549
9.

Powdered red yeast rice and plant stanols and sterols to lower cholesterol.

Feuerstein JS, Bjerke WS.

J Diet Suppl. 2012 Jun;9(2):110-5. doi: 10.3109/19390211.2012.682645. Epub 2012 Apr 25.

PMID:
22531006
10.

Recent perspectives on the role of nutraceuticals as cholesterol-lowering agents.

Ward N, Sahebkar A, Banach M, Watts G.

Curr Opin Lipidol. 2017 Dec;28(6):495-501. doi: 10.1097/MOL.0000000000000455. Review.

PMID:
28858885
11.

Cholesterol-lowering nutraceuticals and functional foods.

Chen ZY, Jiao R, Ma KY.

J Agric Food Chem. 2008 Oct 8;56(19):8761-73. doi: 10.1021/jf801566r. Epub 2008 Sep 9. Review.

PMID:
18778072
12.
13.

Short-Term Effects of a Combined Nutraceutical on Lipid Level, Fatty Liver Biomarkers, Hemodynamic Parameters, and Estimated Cardiovascular Disease Risk: A Double-Blind, Placebo-Controlled Randomized Clinical Trial.

Cicero AFG, Fogacci F, Bove M, Veronesi M, Rizzo M, Giovannini M, Borghi C.

Adv Ther. 2017 Aug;34(8):1966-1975. doi: 10.1007/s12325-017-0580-1. Epub 2017 Jul 7.

14.

The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols.

Guardamagna O, Abello F, Baracco V, Stasiowska B, Martino F.

Nutr Metab Cardiovasc Dis. 2011 Jun;21(6):424-9. doi: 10.1016/j.numecd.2009.10.015. Epub 2010 Feb 12.

PMID:
20153154
15.
16.

Efficacy of Monascus purpureus Went rice on lowering lipid ratios in hypercholesterolemic patients.

Huang CF, Li TC, Lin CC, Liu CS, Shih HC, Lai MM.

Eur J Cardiovasc Prev Rehabil. 2007 Jun;14(3):438-40.

PMID:
17568245
17.

Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia.

Matsuzaki M, Kita T, Mabuchi H, Matsuzawa Y, Nakaya N, Oikawa S, Saito Y, Sasaki J, Shimamoto K, Itakura H; J-LIT Study Group. Japan Lipid Intervention Trial.

Circ J. 2002 Dec;66(12):1087-95.

18.

Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.

Cziraky MJ, Watson KE, Talbert RL.

J Manag Care Pharm. 2008 Oct;14(8 Suppl):S3-28; quiz S30-1. Review.

PMID:
19891279
19.

Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study.

Alvarez-Sala LA, Cachofeiro V, Masana L, Suarez C, Pinilla B, Plana N, Trias F, Moreno MA, Gambus G, Lahera V, Pintó X.

Clin Ther. 2008 Jan;30(1):84-97. doi: 10.1016/j.linthera.2008.01.013.

PMID:
18343245
20.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group.

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343

Supplemental Content

Support Center